Swedish Orphan Biovitrum AB (B6E.SG)
Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
As of 02:48PM CEST. Market open.
| Previous Close | 23.28 |
| Open | 22.72 |
| Bid | 24.26 x 100000 |
| Ask | 24.42 x 100000 |
| Day's Range | 22.72 - 24.64 |
| 52 Week Range | 16.10 - 26.06 |
| Volume | |
| Avg. Volume | 12 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- PR Newswire
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024
- PR Newswire
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Tuesday, 14 May 2024 at 15.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
- PR Newswire
Sobi publishes Annual and sustainability report for 2023
Swedish Orphan Biovitrum AB (publ) (Sobi®) today published its Annual and sustainability report for 2023. Inspired by caring and powered by science, the integrated report summarises business and strategy, financial performance, and work on sustainability.
© 2024 Yahoo. All rights reserved.